| Organism name | Tripterygium wilfordii | 
|---|---|
| Genus | Tripterygium | 
| Family | Celastraceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Tripterygium wilfordii | 
|---|---|
| Linked NCBI taxonomy ID | 458696 | 
| Linked level | species | 
| Family in NCBI taxonomy | Celastraceae | 
|---|---|
| ID | 4305 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | rosids | 
|---|---|
| ID | 71275 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00000659   | Medioresinol / (+)-Medioresinol | CHEMBL376507 CHEMBL513023 | 2 / 1 / 1 | No. 38 | No. 21 |   | ||
| C00002631   | (+)-Lirioresinol B / (+)-Syringaresinol | CHEMBL361362 CHEMBL402653 | C042192 | 1 / 0 / 0 | No. 38 | No. 21 |   | |
| C00046516   | Wilfornine E | CHEMBL450102 | No. 43 |   | ||||
| C00046977   | Wilfordinine B | No. 43 |   | |||||
| C00001987   | Wilfordin | CHEMBL449308 CHEMBL525628 | No. 43 |   | ||||
| C00046976   | Wilfordinine A | CHEMBL2335702 | No. 43 |   | ||||
| C00046846   | Peritassine A / (+)-Peritassine A | CHEMBL1951082 | No. 43 |   | ||||
| C00013107   | Alatusinine / (8a)-8-(Acetyloxy)-8-deoxo-26-hydroxyevonimine | CHEMBL508998 CHEMBL501360 | No. 43 |   | ||||
| C00013120   | Evonine / [8R-(8R*,9R*,10R*,11S*,12S*,13R*,14R*,15S*,18S*,19S*,20S*,21S*)]-10,13,14,21-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,18,19-decahydro-20-hydroxy-8,18,19,20-tetramethyl-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-5,17,22-trione | CHEMBL449845 CHEMBL1996226 | No. 43 |   | ||||
| C00013126   | Euonymin / Euonymine | CHEMBL346753 CHEMBL503447 | No. 43 |   | ||||
| C00046518   | Wilfornine G | CHEMBL502166 | No. 43 |   | ||||
| C00046517   | Wilfornine F | CHEMBL524497 | No. 43 |   | ||||
| C00013158   | Mayteine / [8R-(8R*,9R*,10R*,11S*,12S*,13R*,14R*,15S*,18S*,19S*,20S*,21S*,22R*)]-10,14,21,22-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-13-(benzoyloxy)-7,8,9,10,12,13,14,15,18,19-decahydro-20-hydroxy-8,18,19,20-tetramethyl-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-5,17-dione | CHEMBL526919 CHEMBL1813072 | C096143 | No. 43 |   | |||
| C00046978   | Wilfordinine C | No. 43 |   | |||||
| C00013191   | Wilforidine / (8R,9R,10R,11S,12S,13R,14R,15S,21S,22S,23R)-[partial]-10,13,22,23-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-14,18,21-trihydroxy-8,18,21-trimethyl-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17-dione | CHEMBL504312 CHEMBL1950977 | No. 43 |   | ||||
| C00013193   | Wilforine / (8alpha)-8-(Acetyloxy)-O2-benzoyl-O2-deacetyl-8-deoxoevonimine | CHEMBL503312 CHEMBL502742 | No. 43 |   | ||||
| C00013194   | Wilforzine / O6-Deacetylwilforine / ((8alpha)-8-(Acetyloxy)-O2-benzoyl-O2,O6-dideacetyl-8-deoxoevonimine | No. 43 |   | |||||
| C00046515   | Wilfornine D | No. 43 |   | |||||
| C00046514   | Wilfornine C | CHEMBL509162 | No. 43 |   | ||||
| C00046513   | Wilfornine B | CHEMBL525210 | No. 43 |   | ||||
| C00039395   | Hyponine D | CHEMBL504037 | No. 43 |   | ||||
| C00041008   | Hypoglaunine C / (+)-Hypoglaunine C | CHEMBL501891 | No. 43 |   | ||||
| C00041944   | Tripfordine A | CHEMBL504312 CHEMBL1950977 | No. 43 |   | ||||
| C00041945   | Tripfordine B | CHEMBL453463 | No. 43 |   | ||||
| C00046511   | Wilfordinine J | CHEMBL511075 | No. 43 |   | ||||
| C00046512   | Wilfornine A | CHEMBL502989 | No. 43 |   | ||||
| C00046510   | Wilfordinine I | CHEMBL508482 | No. 43 |   | ||||
| C00041946   | Tripfordine C | CHEMBL505030 | No. 43 |   | ||||
| C00013156   | Triptofordin D 1 / [3R-(3alpha,5alpha,5aalpha,6alpha,9beta,9aalpha,10R*)]-10-(Acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-4-oxo-2H-3,9a-methano-1-benzoxepin-6-yl ester 3-phenyl-2-propenoic acid | No. 168 |   | |||||
| C00013148   | Triptofordin D 2 / [3R-(3alpha,4alpha,5alpha,5aalpha,6alpha,9beta,9aalpha,10R*)]-4,10-bis(Acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6-yl ester 3-phenyl-2-propenoic acid | No. 168 |   | |||||
| C00049687   | (-)-17-Hydroxy-16alpha-kauran-19-oic acid | CHEMBL511892 CHEMBL481645 CHEMBL448617 CHEMBL456957 | No. 203 | No. 41 |   | |||
| C00049686   | (-)-16alpha-Hydroxykauran-19-oic acid | CHEMBL207260 CHEMBL480070 CHEMBL604095 CHEMBL1760135 | C060419 | 1 / 0 / 0 | No. 203 | No. 41 |   | |
| C00049689   | 16alpha,19-Dihydroxy-ent-kaurane | CHEMBL1760128 | No. 203 | No. 41 |   | |||
| C00049759   | Triptobenzene N / (-)-Triptobenzene N | CHEMBL444235 | No. 355 |   | ||||
| C00049757   | Triptobenzene L / (+)-Triptobenzene L | No. 359 | No. 40 |   | ||||
| C00049755   | Triptobenzene A | No. 760 |   | |||||
| C00049758   | Triptobenzene M / (+)-Triptobenzene M | No. 760 |   | |||||
| C00002609   | Hinokiol / (+)-Hinokiol | CHEMBL16901 | 26 / 24 / 20 | No. 761 | No. 23 |   | ||
| C00041947   | Tripterifordin | CHEMBL484043 | C074970 | No. 925 |   | |||
| C00049760   | Triptoquinone C | No. 1436 |   | |||||
| C00035883   | Triptoquinone B | No. 1436 |   | |||||
| C00013189   | Triptofordin A / (+)-Triptofordin A / [3R-(3alpha,5beta,5aalpha,6alpha,9beta,9aalpha)]-6-(Benzoyloxy)octahydro-9-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-yl ester 3-phenyl-2-propenoic acid | No. 1678 |   | |||||
| C00002322   | Celabenzine | No. 2404 |   | |||||
| C00049756   | Triptobenzene H | No. 2898 |   | |||||
| C00035770   | Triptinin B / (+)-Triptinin B | No. 2898 |   | |||||
| C00003494   | Triptolide | CHEMBL463763 CHEMBL444360 | C001899 | 6 / 13 / 18 | 20 / 15 | No. 3698 | No. 41 |   | 
| C00003493   | Tripdiolide | CHEMBL486403 | C001898 | No. 3698 | No. 41 |   | ||
| C00035774   | Triptoquinone A | C100591 | No. 4560 |   | ||||
| C00049761   | Triptotin B / (+)-Triptotin B | No. 7621 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000659 | 1 / 0 | 
| P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00049686 | 0 / 0 | 
| Q99700 | Ataxin-2 | Unclassified protein | C00002609 | 1 / 1 | 
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002609 | 0 / 0 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00003494 | 0 / 3 | 
| P06746 | DNA polymerase beta | Enzyme | C00002609 | 0 / 0 | 
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002609 | 1 / 1 | 
| Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002609 | 0 / 0 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00003494 | 11 / 10 | 
| P37840 | Alpha-synuclein | Unclassified protein | C00002609 | 4 / 2 | 
| P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002609 | 0 / 0 | 
| P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00002609 | 0 / 0 | 
| P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00002609 | 1 / 1 | 
| P11387 | DNA topoisomerase 1 | Isomerase | C00002631 | 0 / 0 | 
| P34972 | Cannabinoid receptor 2 | Cannabinoid receptor | C00002609 | 0 / 0 | 
| P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002609 | 2 / 2 | 
| P39748 | Flap endonuclease 1 | Enzyme | C00002609 | 0 / 0 | 
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002609 | 2 / 0 | 
| O75496 | Geminin | Unclassified protein | C00002609 | 0 / 0 | 
| P51151 | Ras-related protein Rab-9A | Unclassified protein | C00003494 | 0 / 0 | 
| Q9Y2T6 | G-protein coupled receptor 55 | Lysophosphatidylinositol receptor | C00002609 | 0 / 0 | 
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002609 | 0 / 0 | 
| P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002609 | 0 / 0 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002609 | 0 / 0 | 
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002609 | 5 / 3 | 
| Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00002609 | 0 / 0 | 
| O15118 | Niemann-Pick C1 protein | Unclassified protein | C00003494 | 1 / 1 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000659 | 0 / 1 | 
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00002609 | 0 / 0 | 
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002609 | 0 / 0 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00002609 | 4 / 3 | 
| Q9GZV3 | High affinity choline transporter 1 | Choline Na-symporter | C00002609 | 1 / 0 | 
| O00255 | Menin | Unclassified protein | C00002609 | 2 / 5 | 
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002609 | 1 / 2 | 
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00003494 | 0 / 1 | 
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00003494 | 1 / 4 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 | C00003494 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00003494 | 
| 840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) | C00003494 | 
| 941 | CD80, B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7 | CD80 molecule | C00003494 | 
| 942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule | C00003494 | 
| 1082 | CGB, CGB3, CGB5, CGB7, CGB8, hCGB | chorionic gonadotropin, beta polypeptide | C00003494 | 
| 1843 | DUSP1, CL100, HVH1, MKP-1, MKP1, PTPN10 | dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) | C00003494 | 
| 2146 | EZH2, ENX-1, ENX1, EZH1, EZH2b, KMT6, KMT6A, WVS, WVS2 | enhancer of zeste homolog 2 (Drosophila) (EC:2.1.1.43) | C00003494 | 
| 3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A | C00003494 | 
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 | C00003494 | 
| 3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | C00003494 | 
| 3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | C00003494 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00003494 | 
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) | C00003494 | 
| 2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | C00003494 | 
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | C00003494 | 
| 6839 | SUV39H1, H3-K9-HMTase_1, KMT1A, MG44, SUV39H | suppressor of variegation 3-9 homolog 1 (Drosophila) (EC:2.1.1.43) | C00003494 | 
| 6863 | TAC1, Hs.2563, NK2, NKNA, NPK, TAC2 | tachykinin, precursor 1 | C00003494 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00003494 | 
| 331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis | C00003494 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| %606641 | Body mass index; bmi | P37231 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #609338 | Carotid intimal medial thickness 1 | P37231 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #114500 | Colorectal cancer; crc | P84022 | 
| #127750 | Dementia, lewy body; dlb | P37840 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 | P14867 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #137800 | Glioma susceptibility 1; glm1 | P37231 | 
| #232300 | Glycogen storage disease ii | P10253 | 
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay | Q03164 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #145000 | Hyperparathyroidism 1; hrpt1 | O00255 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 | P37231 | 
| #613795 | Loeys-dietz syndrome, type 3; lds3 | P84022 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| #131100 | Multiple endocrine neoplasia, type i; men1 | O00255 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #158580 | Neuronopathy, distal hereditary motor, type viia; hmn7a | Q9GZV3 | 
| #257200 | Niemann-pick disease, type a | P17405 | 
| #607616 | Niemann-pick disease, type b | P17405 | 
| #257220 | Niemann-pick disease, type c1; npc1 | O15118 | 
| #601665 | Obesity | P37231 | 
| #168601 | Parkinson disease 1, autosomal dominant; park1 | P37840 | 
| #605543 | Parkinson disease 4, autosomal dominant; park4 | P37840 | 
| #168600 | Parkinson disease, late-onset; pd | P37840 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #172700 | Pick disease of brain | P10636 | 
| #601399 | Platelet disorder, familial, with associated myeloid malignancy | Q01196 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #183090 | Spinocerebellar ataxia 2; sca2 | Q99700 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00033 | Adrenal carcinoma | O00255
                            (related) | 
| H00034 | Carcinoid | O00255
                            (related) | 
| H00045 | Malignant islet cell carcinoma | O00255
                            (related) | 
| H00246 | Primary hyperparathyroidism | O00255
                            (related) | 
| H01102 | Pituitary adenomas | O00255
                            (related) | 
| H00136 | Niemann-Pick disease type C (NPC) | O15118
                            (related) | 
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) P37231 (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00069 | Glycogen storage diseases (GSD) | P10253
                            (related) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H00808 | Idiopathic generalized epilepsies (IGEs) | P14867
                            (related) | 
| H00137 | Niemann-Pick disease (NPD) typeA and B | P17405
                            (related) | 
| H00424 | Defects in the degradation of sphingomyelin | P17405
                            (related) | 
| H00017 | Esophageal cancer | P35354
                            (related) | 
| H00025 | Penile cancer | P35354
                            (related) | 
| H00046 | Cholangiocarcinoma | P35354
                            (related) | 
| H00032 | Thyroid cancer | P37231
                            (related) | 
| H00409 | Type II diabetes mellitus | P37231
                            (related) | 
| H00057 | Parkinson's disease (PD) | P37840
                            (related) | 
| H00066 | Lewy body dementia (LBD) | P37840
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q01196
                            (related) Q01196 (marker) Q03164 (related) Q03164 (marker) | 
| H00003 | Acute myeloid leukemia (AML) | Q01196
                            (related) Q01196 (marker) Q13951 (marker) | 
| H00004 | Chronic myeloid leukemia (CML) | Q01196
                            (related) | 
| H00978 | Thrombocytopenia (THC) | Q01196
                            (related) | 
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) | Q03164
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q99700
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D058186 | Acute Kidney Injury | C00003494 | 
| D000855 | Anorexia | C00003494 | 
| D003967 | Diarrhea | C00003494 | 
| D056486 | Drug-Induced Liver Injury | C00003494 | 
| D005234 | Fatty Liver | C00003494 | 
| D007249 | Inflammation | C00003494 | 
| D007674 | Kidney Diseases | C00003494 | 
| D015470 | Leukemia, Myeloid, Acute | C00003494 | 
| D009101 | Multiple Myeloma | C00003494 | 
| D009102 | Multiple Organ Failure | C00003494 | 
| D009369 | Neoplasms | C00003494 | 
| D010049 | Ovarian Diseases | C00003494 | 
| D011014 | Pneumonia | C00003494 | 
| D011507 | Proteinuria | C00003494 | 
| D013163 | Splenomegaly | C00003494 |